CervoMed Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CervoMed Inc. (CRVO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 195 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-07
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 0.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 195.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-06-30 was 23.30K shares, a 28.85% increase year-over-year.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-03-31 was 51.00 shares, a 99.86% decline year-over-year.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 42.33K shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 15.96K shares, a 79.45% increase from fiscal 2022.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 8.89K shares, a 97.93% decline from fiscal 2021.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 429.75K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 195.00 shares 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | 195.00 shares 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 42.33K shares 10-K · filed 2026-03-13 | |||
| 2024-06-30 | 23.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 23.35K shares 10-Q · filed 2024-08-09 | ||
| 2024-03-31 | 51.00 shares 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 15.96K shares 10-K · filed 2024-03-29 | |||
| 2023-06-30 | 18.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 54.08K shares 10-Q · filed 2023-08-08 | 55.37K shares derived: sum of 3 quarters · filed 2023-08-08 | 57.36K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 35.99K shares 10-Q · filed 2023-05-15 | 37.28K shares derived: sum of 2 quarters · filed 2023-05-15 | 39.27K shares derived: sum of 3 quarters · filed 2023-05-15 | |
| 2022-12-31 | 1.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | 3.28K shares derived: sum of 2 quarters · filed 2023-03-24 | 8.89K shares 10-K · filed 2023-03-24 | |
| 2022-09-30 | 1.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 7.60K shares 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | 5.61K shares 10-Q · filed 2022-08-12 | |||
| 2021-12-31 | 256.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | 318.32K shares derived: sum of 2 quarters · filed 2022-03-18 | 425.56K shares derived: sum of 3 quarters · filed 2022-03-18 | 429.75K shares 10-K · filed 2022-03-18 |
| 2021-09-30 | 61.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 168.71K shares derived: sum of 2 quarters · filed 2021-11-10 | 172.90K shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 107.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | 111.43K shares 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | 4.19K shares 10-Q · filed 2022-05-12 | |||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-17 | 4.38K shares derived: sum of 3 quarters · filed 2021-03-17 | 11.58K shares 10-K · filed 2021-03-17 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 4.38K shares derived: sum of 2 quarters · filed 2019-11-08 | 11.58K shares 10-Q · filed 2019-11-08 | |
| 2019-06-30 | 4.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 11.58K shares 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | 7.20K shares 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | 10.58K shares 10-K · filed 2020-03-17 | |||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -433.69K shares derived: sum of 2 quarters · filed 2018-04-02 | 44.54K shares derived: sum of 3 quarters · filed 2018-04-02 | 48.19K shares 10-K · filed 2018-04-02 |
| 2016-09-30 | -433.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 44.54K shares derived: sum of 2 quarters · filed 2016-11-14 | 48.19K shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 478.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | 481.88K shares 10-Q · filed 2016-08-15 | ||
| 2016-03-31 | 3.65K shares 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |